298 related articles for article (PubMed ID: 18606765)
21. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.
Kumar D; Singh R; Bhandari V; Kulshrestha A; Negi NS; Salotra P
Parasitol Res; 2012 Jul; 111(1):223-30. PubMed ID: 22302478
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of antimony resistance in Leishmania.
Ashutosh ; Sundar S; Goyal N
J Med Microbiol; 2007 Feb; 56(Pt 2):143-53. PubMed ID: 17244793
[TBL] [Abstract][Full Text] [Related]
24. Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake.
Rugani JN; Gontijo CMF; Frézard F; Soares RP; Monte-Neto RLD
Mem Inst Oswaldo Cruz; 2019; 114():e190111. PubMed ID: 31433006
[TBL] [Abstract][Full Text] [Related]
25. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
[TBL] [Abstract][Full Text] [Related]
26. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.
Zheng Z; Chen J; Ma G; Satoskar AR; Li J
Parasit Vectors; 2020 Oct; 13(1):510. PubMed ID: 33046138
[TBL] [Abstract][Full Text] [Related]
27. Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates.
Mandal G; Sarkar A; Saha P; Singh N; Sundar S; Chatterjee M
Indian J Biochem Biophys; 2009 Feb; 46(1):86-92. PubMed ID: 19374259
[TBL] [Abstract][Full Text] [Related]
28. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence.
Iyer JP; Kaprakkaden A; Choudhary ML; Shaha C
Mol Microbiol; 2008 Apr; 68(2):372-91. PubMed ID: 18312262
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
Ashutosh ; Garg M; Sundar S; Duncan R; Nakhasi HL; Goyal N
Antimicrob Agents Chemother; 2012 Jan; 56(1):518-25. PubMed ID: 22064540
[TBL] [Abstract][Full Text] [Related]
30. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.
Mohebali M; Kazemirad E; Hajjaran H; Kazemirad E; Oshaghi MA; Raoofian R; Teimouri A
Arch Dermatol Res; 2019 Jan; 311(1):9-17. PubMed ID: 30390113
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance mechanisms in clinical isolates of Leishmania donovani.
Singh N
Indian J Med Res; 2006 Mar; 123(3):411-22. PubMed ID: 16778320
[TBL] [Abstract][Full Text] [Related]
32. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.
Moreira DS; Monte Neto RL; Andrade JM; Santi AM; Reis PG; Frézard F; Murta SM
Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():143-53. PubMed ID: 24533304
[TBL] [Abstract][Full Text] [Related]
34. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
Pal S; Mandal A; Duttagupta S
Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
[TBL] [Abstract][Full Text] [Related]
35. Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen.
El Fadili K; Drummelsmith J; Roy G; Jardim A; Ouellette M
Exp Parasitol; 2009 Sep; 123(1):51-7. PubMed ID: 19500579
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis.
Figarella K; Uzcategui NL; Zhou Y; LeFurgey A; Ouellette M; Bhattacharjee H; Mukhopadhyay R
Mol Microbiol; 2007 Aug; 65(4):1006-17. PubMed ID: 17640270
[TBL] [Abstract][Full Text] [Related]
37. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
[TBL] [Abstract][Full Text] [Related]
38. Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.
Andrade JM; Baba EH; Machado-de-Avila RA; Chavez-Olortegui C; Demicheli CP; Frézard F; Monte-Neto RL; Murta SM
Antimicrob Agents Chemother; 2016 Aug; 60(8):4482-9. PubMed ID: 27161624
[TBL] [Abstract][Full Text] [Related]
39. A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.
Genest PA; Haimeur A; Légaré D; Sereno D; Roy G; Messier N; Papadopoulou B; Ouellette M
Mol Biochem Parasitol; 2008 Mar; 158(1):95-9. PubMed ID: 18164495
[TBL] [Abstract][Full Text] [Related]
40. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
